Bharat Biotech has obtained the license to manufacture COVAXIN for the sale and distribution. The licensing authority granted the license on Jan 03, 2021 but the firm will have to submit the safety data with all the detailed analysis every 15 days for the first 2 months and then every month from there on. Each and every batch of the vaccination will be distributed from the Central Drugs Laboratory in Kasauli. The SEC has also granted permission to Serum’s “Covishield” for emergency use to help fight the battle against COVID-19.